Selective expansion of CD34+ cells from mouse bone marrow cultured on LH/P MP-coated plates with adequate cytokines

Journal of Tissue Engineering

Volumn 2, Issue 1, 2011, Pages 1-8

  Kishimoto, Satoko ^a,b,d   Ishihara, Masayuki ^a   Kanatani, Yasuhiro ^c   Nambu, Masaki ^a   Takikawa, Megumi ^a   Sumi, Yuki ^a   Nakamura, Shingo ^a   Mori, Yasutaka ^a   Hattori, Hidemi ^a   Tanaka, Yoshihiro ^a   Sato, Toshinori ^d  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^d KEIO UNIVERSITY   (Japan)

Author keywords

CD34 positive hematopoietic cells (CD34 cells); Cell proliferation; Cytokines

Indexed keywords

BONE; MAMMALS; PLASTIC COATINGS; POLYSACCHARIDES; STEM CELLS; TISSUE CULTURE;

CD34+ CELLS; CD34-POSITIVE HEMATOPOIETIC CELL; CELL-BE; CELL/B.E; CELL/BE; CYTOKINES; HEMATOPOIETIC CELL; LOW-MOLECULAR WEIGHT HEPARINS; MICRO PARTICLES; MOUSE BONES;

CELL PROLIFERATION;

EID: 84890195525     PISSN: None     EISSN: 20417314     Source Type: Journal    
DOI: 10.1177/2041731411425419     Document Type: Article

References (32)

1. Stella CC, Cazzola M, Fabritiis PD, et al. CD34-positive cells: biology and clinical relevance. Haematologica 1995; 80(4): 367-387.
2. Guo S, Cheng Y, Ma Y, et al. Endothelial progenitor cells derived from CD34+ cells from cooperative vascular networks. Cell Physiol Biochem 2010; 26(4-5): 679-688.
3. Wang J, Zhang S, Rabinovich B, et al. Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res 2010; 106(12): 1904-1911.
4. Moioli EK, Clark PA, Chen M, et al. Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One 2008; 3(12): e3922.
5. Sutherland RD, Keating A. The CD34 antigen: structure, biology and potential clinical application. J Hematother 1992; 1(2): 115-129.
6. Andrews RG, Singer JW, Bernstein ID. Monoclonal antibody 12.8 recognizes a 115 kD molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986; 67(3): 842-852.
7. Yura H, Kanatani Y, Ishihara M, et al. Selection of hematopoietic stem cells with combination of galactose-bound vinyl polymer and soybean agglutinin, a galactose-specific lectin. Transfusion 2008; 48(3): 561-566.
8. Traycott CM, Abboud MR, Laver J, et al. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential. Exp Hematol 1994; 22(13): 1264-1272.
9. Parmar K, Mauch P, Vergilio JA, et al. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A 2007; 104(13): 5431-5436.
10. Hung SC, Chen NJ, Hsieh SL, et al. Isolation and characterization of size-sieved stem cells from human bone marrow. Stem Cells 2002; 20(3): 249-258.
11. Hofmeister CC, Zhang J, Knight KL, et al. Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant 2007; 39(1): 11-23.
12. Wilson A, Trumpp A. Bone-marrow haemetopoietic-stem-cell niches. Nat Rev Immunol 2006; 6(2): 93-106.
13. Moore KA, Lemischka IR. Stem cells and their niches. Science 2006; 311(5769): 1880-1885.
14. Zubler RH. Ex vivo expansion of haematopoietic stem cells and gene therapy development. Swiss Med Wkly 2006; 136(49-50): 795-799.
15. Gupta P, Oegema TR Jr, Brazil JJ, et al. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood 1998; 92(13): 4641-4651.
16. Alvarez-Silva M, Borojevic R. GM-CSF and IL-3 activities in schistosomal liver granulomas are controlled by stroma-associated heparan sulfate proteoglycans. J Leukoc Biol 1996; 59(3): 435-441.
17. Roberts R, Gallagher J, Spooncer E, et al. Heparan sulfate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 1988; 332(6162): 376-378.
18. Gordon MY, Riley GP, Watt SM, Greaves MF. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987; 326(6111): 403-405.
19. Kishimoto S, Nakamura S, Nakamura SI, et al. Cytokine-immobilized microparticle-coated plates for culturing hematopoietic progenitor cells. J Control Release 2009; 133(3): 185-190.
20. Kishimoto S, Nakamura S, Hattori H, et al. Human stem cell factor (SCF) is a heparin-binding cytokine. J Biochem 2009; 145(3): 275-278.
21. Ishihara M, Ono K. Structure and function of heparin and heparan sulfate: heparinoid library and modification of FGF-activities. Trends Glycosci Glycotechnol 1998; 10(52): 223-233.
22. Ishihara M. Biosynthesis, structure, and biological activity of basic FGF binding domains of heparan sulfate. Trends Glycosci Glycotechnol 1993; 5(25): 343-354.
23. Salmivirta M, Lidholt K, Lindahl U. Heparan sulfate: a piece of information. FASEB J 1996; 10(11): 1270-1279.
24. Lindahl U, Lidholt K, Spillmann D, Kjellen L. More to 'heparin' than anticoagulation. Thromb Res 1994; 75(1): 1-32.
25. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119(1): 64S-94S.
26. Wolzt M, Wetermann A, Nieszpaur-Los M, et al. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (FragminR) at the site of activation of the coagulation system in man. Thromb Haemost 1995; 73(3): 439-443.
27. Pan M, Lezo JS, Medina A, et al. In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am J Cardiol 1997; 80(10): 1336-1338.
28. Nakamura S, Kanatani Y, Kishimoto S, et al. Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization. J Biomed Mater Res A 2009; 91(3): 814-823.
29. Nakamura S, Nambu M, Ishizuka T, et al. Effect ofcontrolled release of fibroblast growth factor-2 fromchitosan/fucoidan micro complex hydrogel on in vitro and in vivo vascularization. J Biomed Mater Res A 2008; 85(3): 619-627.
30. Okamoto T, Takagi M, Soma T, et al. Effect of heparin addition on expansion of cord blood hematopoietic progenitor cells in three-dimensional coculture with stromal cells in nonwoven fabrics. J Artif Organs 2004; 7(4): 194-202.
31. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993; 81(11): 2844-2853.
32. Sonoda Y, Yang YC, Wong GG, et al. Analysis in serum-free culture of the targets of recombinant human hematopoietic factors: interleukin-3 and granulocyte/macrophage colony-stimulating factor are specific for early developmental stages. Proc Natl Acad Sci U S A, 1988; 85(12): 4360-4364.